-
U.S. House Passes Bioterrorism, Drug Review Bill
WASHINGTON - The U.S. House Wednesday approved a bill to increase funding for bioterrorism preparedness by $4.6 billion and to renew the law under which prescription drugmakers pay "user fees" to the FDA to speed the drug review process, Reuters reports.